Revised ICD-10-PCS Codes in

62 code descriptions were modified in the 2022 ICD-10-PCS code set, effective October 1, 2021.

Displaying codes 1-62 of 62:

  • 3E00X0M Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach
    • Old long description: Introduction of Monoclonal Antibody into Skin and Mucous Membranes, External Approach
  • 3E0130M Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach
  • 3E0230M Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Muscle, Percutaneous Approach
  • 3E0300M Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approach
    • Old long description: Introduction of Monoclonal Antibody into Peripheral Vein, Open Approach
  • 3E0330M Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Peripheral Vein, Percutaneous Approach
  • 3E0400M Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach
    • Old long description: Introduction of Monoclonal Antibody into Central Vein, Open Approach
  • 3E0430M Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Central Vein, Percutaneous Approach
  • 3E0500M Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach
    • Old long description: Introduction of Monoclonal Antibody into Peripheral Artery, Open Approach
  • 3E0530M Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Peripheral Artery, Percutaneous Approach
  • 3E0600M Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Open Approach
    • Old long description: Introduction of Monoclonal Antibody into Central Artery, Open Approach
  • 3E0630M Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Central Artery, Percutaneous Approach
  • 3E0930M Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Nose, Percutaneous Approach
  • 3E0970M Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Nose, Via Natural or Artificial Opening
  • 3E09X0M Introduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approach
    • Old long description: Introduction of Monoclonal Antibody into Nose, External Approach
  • 3E0A30M Introduction of Antineoplastic, Monoclonal Antibody, into Bone Marrow, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Bone Marrow, Percutaneous Approach
  • 3E0B30M Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Ear, Percutaneous Approach
  • 3E0B70M Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Ear, Via Natural or Artificial Opening
  • 3E0BX0M Introduction of Antineoplastic, Monoclonal Antibody, into Ear, External Approach
    • Old long description: Introduction of Monoclonal Antibody into Ear, External Approach
  • 3E0C30M Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Eye, Percutaneous Approach
  • 3E0C70M Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Eye, Via Natural or Artificial Opening
  • 3E0CX0M Introduction of Antineoplastic, Monoclonal Antibody, into Eye, External Approach
    • Old long description: Introduction of Monoclonal Antibody into Eye, External Approach
  • 3E0D30M Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Mouth and Pharynx, Percutaneous Approach
  • 3E0D70M Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Mouth and Pharynx, Via Natural or Artificial Opening
  • 3E0DX0M Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, External Approach
    • Old long description: Introduction of Monoclonal Antibody into Mouth and Pharynx, External Approach
  • 3E0E30M Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Products of Conception, Percutaneous Approach
  • 3E0E70M Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Products of Conception, Via Natural or Artificial Opening
  • 3E0E80M Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopic
    • Old long description: Introduction of Monoclonal Antibody into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0F30M Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Respiratory Tract, Percutaneous Approach
  • 3E0F70M Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Respiratory Tract, Via Natural or Artificial Opening
  • 3E0F80M Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
    • Old long description: Introduction of Monoclonal Antibody into Respiratory Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0G30M Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Upper GI, Percutaneous Approach
  • 3E0G70M Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Upper GI, Via Natural or Artificial Opening
  • 3E0G80M Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening Endoscopic
    • Old long description: Introduction of Monoclonal Antibody into Upper GI, Via Natural or Artificial Opening Endoscopic
  • 3E0H30M Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Lower GI, Percutaneous Approach
  • 3E0H70M Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Lower GI, Via Natural or Artificial Opening
  • 3E0H80M Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening Endoscopic
    • Old long description: Introduction of Monoclonal Antibody into Lower GI, Via Natural or Artificial Opening Endoscopic
  • 3E0J30M Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J70M Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
  • 3E0J80M Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
    • Old long description: Introduction of Monoclonal Antibody into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0K30M Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Genitourinary Tract, Percutaneous Approach
  • 3E0K70M Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Genitourinary Tract, Via Natural or Artificial Opening
  • 3E0K80M Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
    • Old long description: Introduction of Monoclonal Antibody into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic
  • 3E0L30M Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Pleural Cavity, Percutaneous Approach
  • 3E0L70M Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Pleural Cavity, Via Natural or Artificial Opening
  • 3E0M30M Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Peritoneal Cavity, Percutaneous Approach
  • 3E0M70M Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Peritoneal Cavity, Via Natural or Artificial Opening
  • 3E0N30M Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Male Reproductive, Percutaneous Approach
  • 3E0N70M Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Male Reproductive, Via Natural or Artificial Opening
  • 3E0N80M Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening Endoscopic
    • Old long description: Introduction of Monoclonal Antibody into Male Reproductive, Via Natural or Artificial Opening Endoscopic
  • 3E0P30M Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Female Reproductive, Percutaneous Approach
  • 3E0P70M Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Female Reproductive, Via Natural or Artificial Opening
  • 3E0P80M Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening Endoscopic
    • Old long description: Introduction of Monoclonal Antibody into Female Reproductive, Via Natural or Artificial Opening Endoscopic
  • 3E0Q00M Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Open Approach
    • Old long description: Introduction of Monoclonal Antibody into Cranial Cavity and Brain, Open Approach
  • 3E0Q30M Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Cranial Cavity and Brain, Percutaneous Approach
  • 3E0Q70M Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Cranial Cavity and Brain, Via Natural or Artificial Opening
  • 3E0R30M Introduction of Antineoplastic, Monoclonal Antibody, into Spinal Canal, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Spinal Canal, Percutaneous Approach
  • 3E0S30M Introduction of Antineoplastic, Monoclonal Antibody, into Epidural Space, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Epidural Space, Percutaneous Approach
  • 3E0U30M Introduction of Antineoplastic, Monoclonal Antibody, into Joints, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Joints, Percutaneous Approach
  • 3E0V30M Introduction of Antineoplastic, Monoclonal Antibody, into Bones, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Bones, Percutaneous Approach
  • 3E0W30M Introduction of Antineoplastic, Monoclonal Antibody, into Lymphatics, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Lymphatics, Percutaneous Approach
  • 3E0Y30M Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Percutaneous Approach
    • Old long description: Introduction of Monoclonal Antibody into Pericardial Cavity, Percutaneous Approach
  • 3E0Y70M Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Via Natural or Artificial Opening
    • Old long description: Introduction of Monoclonal Antibody into Pericardial Cavity, Via Natural or Artificial Opening
ICD-10-PCS 3E00X0M
ICD-10-PCS 3E0130M
ICD-10-PCS 3E0230M
ICD-10-PCS 3E0300M
ICD-10-PCS 3E0330M
ICD-10-PCS 3E0400M
ICD-10-PCS 3E0430M
ICD-10-PCS 3E0500M
ICD-10-PCS 3E0530M
ICD-10-PCS 3E0600M
ICD-10-PCS 3E0630M
ICD-10-PCS 3E0930M
ICD-10-PCS 3E0970M
ICD-10-PCS 3E09X0M
ICD-10-PCS 3E0A30M
ICD-10-PCS 3E0B30M
ICD-10-PCS 3E0B70M
ICD-10-PCS 3E0BX0M
ICD-10-PCS 3E0C30M
ICD-10-PCS 3E0C70M
ICD-10-PCS 3E0CX0M
ICD-10-PCS 3E0D30M
ICD-10-PCS 3E0D70M
ICD-10-PCS 3E0DX0M
ICD-10-PCS 3E0E30M
ICD-10-PCS 3E0E70M
ICD-10-PCS 3E0E80M
ICD-10-PCS 3E0F30M
ICD-10-PCS 3E0F70M
ICD-10-PCS 3E0F80M
ICD-10-PCS 3E0G30M
ICD-10-PCS 3E0G70M
ICD-10-PCS 3E0G80M
ICD-10-PCS 3E0H30M
ICD-10-PCS 3E0H70M
ICD-10-PCS 3E0H80M
ICD-10-PCS 3E0J30M
ICD-10-PCS 3E0J70M
ICD-10-PCS 3E0J80M
ICD-10-PCS 3E0K30M
ICD-10-PCS 3E0K70M
ICD-10-PCS 3E0K80M
ICD-10-PCS 3E0L30M
ICD-10-PCS 3E0L70M
ICD-10-PCS 3E0M30M
ICD-10-PCS 3E0M70M
ICD-10-PCS 3E0N30M
ICD-10-PCS 3E0N70M
ICD-10-PCS 3E0N80M
ICD-10-PCS 3E0P30M
ICD-10-PCS 3E0P70M
ICD-10-PCS 3E0P80M
ICD-10-PCS 3E0Q00M
ICD-10-PCS 3E0Q30M
ICD-10-PCS 3E0Q70M
ICD-10-PCS 3E0R30M
ICD-10-PCS 3E0S30M
ICD-10-PCS 3E0U30M
ICD-10-PCS 3E0V30M
ICD-10-PCS 3E0W30M
ICD-10-PCS 3E0Y30M
ICD-10-PCS 3E0Y70M